Humacyte, Inc.
$0.00
+0.00 (+0.00%)
Price as of Aug 26, 2026 market close
Performance
- 1 Month
- -90.0%
- 3 Months
- -98.4%
- YTD
- -99.0%
- 1 Year
- -99.5%
- 3 Year annualized
- -89.5%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 247.2%
- Largest decline max drawdown, since Sep 2021
- -100.0%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.73
Own HUMAW?
See how HUMAW contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.